Tom Crake
Hammersmith Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tom Crake.
Circulation | 1993
David C. Lefroy; Tom Crake; Neal G. Uren; G Davies; Attilio Maseri
BackgroundNG Monomethyl-L-arginine (L-NMMA), a specific inhibitor of nitric oxide synthesis, was used to determine the effects of inhibition of nitric oxide synthesis in the human coronary circulation. Methods and ResultsTwelve patients (mean age, 52
Journal of the American College of Cardiology | 1991
Petros Nihoyannopoulos; Juan Carlos Kaski; Tom Crake; Attilio Maseri
2 years) with normal epicardial coronary arteries were studied. The surface ECG, systemic blood pressure, and coronary venous oxygen saturation (coronary Svo2), an index of coronary blood flow, were monitored continuously. Coronary artery diameter was measured by quantitative arteriography. L-NMMA was given as intracoronary infusions at 2 mLlmin via the diagnostic arteriography catheter. In two patients, low doses (0.01 to 5 gmol/min) of L-NMMA were infused into the nondominant right coronary artery. There was no evidence of ischemia in these patients, who were not included in the final analysis. In 10 patients, higher doses ofL-NMMA (4, 10, and 25
The Lancet | 1991
AdrianJ.B. Brady; Tom Crake; C. M. Oakley
μmol/min, each for 5 minutes) were infused into the left coronary artery. In six patients, incremental doses of acetylcholine were infused (1, 10, and 100 nmol/min, each for 3 minutes) before and after the L-NMMA infusion. Finally, in all patients, sodium nitroprusside, a nitric oxide donor, was infused. No patient developed myocardial ischemia. The heart rate and systemic blood pressure remained unchanged throughout the infusions. L-NMMA (25 Atmol/min), compared with the control saline infusion, caused a significant reduction in distal (-5.9
The Lancet | 1986
ArshedA. Quyyumi; MichaelB. Rubens; AnthonyF. Rickards; Tom Crake; RichardD. Levy; K M Fox
2.1%, p=0.021) but not proximal left anterior descending coronary artery (LAD) diameter and a fall in coronary Svo2 from 37.5
American Heart Journal | 1993
Filippo Crea; Graham Davies; Tom Crake; Achille Gaspardone; Alfredo R. Galassi; Juan Carlos Kaski; Attilio Maseri
2.8% to 34.3
Journal of the American College of Cardiology | 1993
Dimitris Tousoulis; Tom Crake; David C. Lefroy; Alfredo R. Galassi; Attilio Maseri
2.8% (P=0.019). Sodium nitroprusside dilated the proximal (17.8
Journal of the American College of Cardiology | 1992
Neal G. Uren; Peter F. Ludman; Tom Crake; Celia M. Oakley
6.9%o, P=0.033) and distal (24.5
Atherosclerosis | 1999
Costas Tentolouris; Dimitris Tousoulis; Tom Crake; Geogre Katsimaglis; Christodoulos Stefanadis; Graham Davies; P. Toutouzas
6.5%, P=0.006) LAD and increased the coronary Svo2 to 61.6
Journal of Thrombosis and Thrombolysis | 1998
Felicita Andreotti; David C. Lefroy; Alessandro Sciahbasi; Tom Crake; Attilio Maseri; Eugenia De Marco; Graham Davies
5.0%o (p=0.0002). Acetylcholine caused significant dilatation of the distal (13.8
Cardiovascular Research | 1996
Neal G. Uren; Tom Crake; David C. Lefroy; Graham Davies; Attilio Maseri
5.4%, P=0.049) but not proximal LAD and a significant increase in coronary Svo2 from 36.5